Literature DB >> 18066457

Ambulatory blood pressure monitoring and type 2 diabetes mellitus.

Cristiane Bauermann Leitão1, Luís Henrique Canani, Sandra Pinho Silveiro, Jorge Luiz Gross.   

Abstract

Hypertension is one of the main risk factors for the onset and progression of chronic complications in type 2 diabetes mellitus (DM). Ambulatory blood pressure (BP) monitoring (ABPM) provides a better correlation with target organ lesions than BP obtained in the office. Furthermore, it allows the evaluation of distinct BP parameters such as the 24-h, daytime and nighttime systolic and diastolic BP means, BP loads and the absence of nocturnal drop of BP, as well as the identification of white-coat and masked hypertension. DM patients have higher daytime and nighttime BP means than non-DM patients. In addition, one third of normotensive type 2 DM patients have masked hypertension, which is associated with an increase in albuminuria and in left ventricle wall thickness. On the other hand, the prevalence and effect of white-coat hypertension in type 2 DM patients have not yet been properly evaluated. The absence of nocturnal drop of BP does not add information to the 24 h, daytime or nighttime BP measurements, but the nighttime BP means seem to be relevant in DM retinopathy. In conclusion, BP determination by ABPM allows better patient risk stratification for the development of DM chronic complications and is an essential instrument for effective BP control in these patients.

Entities:  

Mesh:

Year:  2007        PMID: 18066457     DOI: 10.1590/s0066-782x2007001700012

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  7 in total

1.  Relationship between mean platelet volume and retinopathy in patients with type 2 diabetes mellitus.

Authors:  Esra Ayhan Tuzcu; Secil Arıca; Nılufer Ilhan; Mutlu Daglioglu; Mesut Coskun; Ozgur Ilhan; Ihsan Ustun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-08-17       Impact factor: 3.117

2.  Risk factors associated with retinal neovascularization of diabetic retinopathy in type 2 diabetes mellitus.

Authors:  Ze-Long Zhong; Mei Han; Song Chen
Journal:  Int J Ophthalmol       Date:  2011-04-18       Impact factor: 1.779

3.  Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes.

Authors:  João S Felício; Ana Carolina C B de Souza; Nárcia Kohlmann; Oswaldo Kohlmann; Arthur B Ribeiro; Maria T Zanella
Journal:  Cardiovasc Diabetol       Date:  2010-08-13       Impact factor: 9.951

Review 4.  Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions.

Authors:  J Peacock; K M Diaz; A J Viera; J E Schwartz; D Shimbo
Journal:  J Hum Hypertens       Date:  2014-02-27       Impact factor: 3.012

Review 5.  White-coat hypertension should not be treated in subjects with diabetes.

Authors:  Michael Bursztyn; Iddo Z Ben-Dov
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

6.  Plasma plasminogen activator inhibitor-1 is associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population.

Authors:  Ze-long Zhong; Song Chen
Journal:  Exp Diabetes Res       Date:  2012-10-14

Review 7.  Present Insights on Cardiomyopathy in Diabetic Patients.

Authors:  João Soares Felício; Camila Cavalcante Koury; Carolina Tavares Carvalho; João Felício Abrahão Neto; Karem Barbosa Miléo; Thaís Pontes Arbage; Denisson Dias Silva; Alana Ferreira de Oliveira; Amanda Soares Peixoto; Antônio Bentes Figueiredo; Ândrea Kely Campos Ribeiro Dos Santos; Elizabeth Sumi Yamada; Maria Teresa Zanella
Journal:  Curr Diabetes Rev       Date:  2016
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.